Health
Study shows reliability and robustness of injectable anti-obesity medication – News-Medical.Net
A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing…
A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug. With obesity affecting more than 40 percent of American adults, the findings could have a major impact on weight management in primary care and other settings. The study is published today in the Journal of the American Medical Association.
The 68-week study was conducted at 41 sites in the…
-
Business24 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News24 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Noosa News24 hours agoDid AI write your accounting expert’s report? – Proctor
-
General23 hours agoWith a deal on Australia’s environmental laws, Murray Watt has cemented his reputation as a ‘fixer’